Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma

Tao Xu, Anyou Zhu, Meiqun Sun, Jingzhu Lv, Zhongqing Qian, Xiaojing Wang, Ting Wang, Hongtao Wang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hepatitis B is one of the most common infectious diseases, which leads to public health problems in the world, especially in Asian counties. In recent years, extensive human genetic association studies have been carried out to identify susceptible genes and genetic polymorphisms to understand the genetic contributions to the disease progression of HBV infection. HLA-DQ gene variations have been reported to be associated with HBV infection/clearance, disease progression and the development of hepatitis B-related complications, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC). However, the results are either inconclusive or controversial. Therefore, to derive a more precise estimation of the association, a meta-analysis was performed. Our data revealed that the HLA-DQ alleles rs2856718-G, rs7453920-A and rs9275319-G were significantly associated with decreased risk of HBV infection and HBV natural clearance. Logistic regression analyses showed that HLA-DQ alleles rs9275572-A significantly increased HBV infection clearance, and decreased HBV natural clearance. However, rs2856718-G and rs9275572-A were not associated with development of cirrhosis. The HLA-DQ polymorphisms (rs2856718 and rs9275572) were associated with a decreased HBV-related HCC risk in all genetic models, but rs9272105-A increased the risk of HBV-related HCC. In addition, no significant association was observed between HLA-DQ rs9275319-G polymorphism and HBVrelated HCC. These stratified analyses were limited due to relatively modest size of correlational studies. In future, further investigation on a large population and different ethnicities are warranted. Our findings contribute to the personalized care and prognosis in hepatitis B.

Original languageEnglish (US)
Pages (from-to)96-109
Number of pages14
JournalOncotarget
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

HLA-DQ Antigens
Virus Diseases
Hepatitis B virus
Liver Cirrhosis
Hepatocellular Carcinoma
Hepatitis B
Genes
Infection
Disease Progression
Alleles
Genetic Models
Medical Genetics
Genetic Association Studies
Genetic Polymorphisms
Communicable Diseases
Meta-Analysis
Fibrosis
Public Health
Logistic Models
Regression Analysis

Keywords

  • Hepatitis B virus
  • Hepatocellular carcinoma
  • HLA-DQ
  • Immune response
  • Immunity
  • Immunology and Microbiology Section
  • Liver cirrhosis
  • Polymorphism

ASJC Scopus subject areas

  • Oncology

Cite this

Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma. / Xu, Tao; Zhu, Anyou; Sun, Meiqun; Lv, Jingzhu; Qian, Zhongqing; Wang, Xiaojing; Wang, Ting; Wang, Hongtao.

In: Oncotarget, Vol. 9, No. 1, 01.01.2018, p. 96-109.

Research output: Contribution to journalArticle

Xu, Tao ; Zhu, Anyou ; Sun, Meiqun ; Lv, Jingzhu ; Qian, Zhongqing ; Wang, Xiaojing ; Wang, Ting ; Wang, Hongtao. / Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma. In: Oncotarget. 2018 ; Vol. 9, No. 1. pp. 96-109.
@article{d7687e44f7e44d04aef798ac5feb896c,
title = "Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma",
abstract = "Hepatitis B is one of the most common infectious diseases, which leads to public health problems in the world, especially in Asian counties. In recent years, extensive human genetic association studies have been carried out to identify susceptible genes and genetic polymorphisms to understand the genetic contributions to the disease progression of HBV infection. HLA-DQ gene variations have been reported to be associated with HBV infection/clearance, disease progression and the development of hepatitis B-related complications, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC). However, the results are either inconclusive or controversial. Therefore, to derive a more precise estimation of the association, a meta-analysis was performed. Our data revealed that the HLA-DQ alleles rs2856718-G, rs7453920-A and rs9275319-G were significantly associated with decreased risk of HBV infection and HBV natural clearance. Logistic regression analyses showed that HLA-DQ alleles rs9275572-A significantly increased HBV infection clearance, and decreased HBV natural clearance. However, rs2856718-G and rs9275572-A were not associated with development of cirrhosis. The HLA-DQ polymorphisms (rs2856718 and rs9275572) were associated with a decreased HBV-related HCC risk in all genetic models, but rs9272105-A increased the risk of HBV-related HCC. In addition, no significant association was observed between HLA-DQ rs9275319-G polymorphism and HBVrelated HCC. These stratified analyses were limited due to relatively modest size of correlational studies. In future, further investigation on a large population and different ethnicities are warranted. Our findings contribute to the personalized care and prognosis in hepatitis B.",
keywords = "Hepatitis B virus, Hepatocellular carcinoma, HLA-DQ, Immune response, Immunity, Immunology and Microbiology Section, Liver cirrhosis, Polymorphism",
author = "Tao Xu and Anyou Zhu and Meiqun Sun and Jingzhu Lv and Zhongqing Qian and Xiaojing Wang and Ting Wang and Hongtao Wang",
year = "2018",
month = "1",
day = "1",
doi = "10.18632/oncotarget.22941",
language = "English (US)",
volume = "9",
pages = "96--109",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "1",

}

TY - JOUR

T1 - Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma

AU - Xu, Tao

AU - Zhu, Anyou

AU - Sun, Meiqun

AU - Lv, Jingzhu

AU - Qian, Zhongqing

AU - Wang, Xiaojing

AU - Wang, Ting

AU - Wang, Hongtao

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Hepatitis B is one of the most common infectious diseases, which leads to public health problems in the world, especially in Asian counties. In recent years, extensive human genetic association studies have been carried out to identify susceptible genes and genetic polymorphisms to understand the genetic contributions to the disease progression of HBV infection. HLA-DQ gene variations have been reported to be associated with HBV infection/clearance, disease progression and the development of hepatitis B-related complications, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC). However, the results are either inconclusive or controversial. Therefore, to derive a more precise estimation of the association, a meta-analysis was performed. Our data revealed that the HLA-DQ alleles rs2856718-G, rs7453920-A and rs9275319-G were significantly associated with decreased risk of HBV infection and HBV natural clearance. Logistic regression analyses showed that HLA-DQ alleles rs9275572-A significantly increased HBV infection clearance, and decreased HBV natural clearance. However, rs2856718-G and rs9275572-A were not associated with development of cirrhosis. The HLA-DQ polymorphisms (rs2856718 and rs9275572) were associated with a decreased HBV-related HCC risk in all genetic models, but rs9272105-A increased the risk of HBV-related HCC. In addition, no significant association was observed between HLA-DQ rs9275319-G polymorphism and HBVrelated HCC. These stratified analyses were limited due to relatively modest size of correlational studies. In future, further investigation on a large population and different ethnicities are warranted. Our findings contribute to the personalized care and prognosis in hepatitis B.

AB - Hepatitis B is one of the most common infectious diseases, which leads to public health problems in the world, especially in Asian counties. In recent years, extensive human genetic association studies have been carried out to identify susceptible genes and genetic polymorphisms to understand the genetic contributions to the disease progression of HBV infection. HLA-DQ gene variations have been reported to be associated with HBV infection/clearance, disease progression and the development of hepatitis B-related complications, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC). However, the results are either inconclusive or controversial. Therefore, to derive a more precise estimation of the association, a meta-analysis was performed. Our data revealed that the HLA-DQ alleles rs2856718-G, rs7453920-A and rs9275319-G were significantly associated with decreased risk of HBV infection and HBV natural clearance. Logistic regression analyses showed that HLA-DQ alleles rs9275572-A significantly increased HBV infection clearance, and decreased HBV natural clearance. However, rs2856718-G and rs9275572-A were not associated with development of cirrhosis. The HLA-DQ polymorphisms (rs2856718 and rs9275572) were associated with a decreased HBV-related HCC risk in all genetic models, but rs9272105-A increased the risk of HBV-related HCC. In addition, no significant association was observed between HLA-DQ rs9275319-G polymorphism and HBVrelated HCC. These stratified analyses were limited due to relatively modest size of correlational studies. In future, further investigation on a large population and different ethnicities are warranted. Our findings contribute to the personalized care and prognosis in hepatitis B.

KW - Hepatitis B virus

KW - Hepatocellular carcinoma

KW - HLA-DQ

KW - Immune response

KW - Immunity

KW - Immunology and Microbiology Section

KW - Liver cirrhosis

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=85040545702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040545702&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.22941

DO - 10.18632/oncotarget.22941

M3 - Article

AN - SCOPUS:85040545702

VL - 9

SP - 96

EP - 109

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 1

ER -